- Home
- FSI vs KRON Comparison
FSI vs KRON Comparison
Compare FSI & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSI
- KRON
- Stock Information
- Founded
- FSI 1991
- KRON 2017
- Country
- FSI Canada
- KRON United States
- Employees
- FSI N/A
- KRON N/A
- Industry
- FSI Recreational Games/Products/Toys
- KRON Medicinal Chemicals and Botanical Products
- Sector
- FSI Consumer Discretionary
- KRON Health Care
- Exchange
- FSI Nasdaq
- KRON Nasdaq
- Market Cap
- FSI 46.5M
- KRON 54.4M
- IPO Year
- FSI 1999
- KRON 2020
- Fundamental
- Price
- FSI $4.28
- KRON $0.71
- Analyst Decision
- FSI
- KRON Buy
- Analyst Count
- FSI 0
- KRON 3
- Target Price
- FSI N/A
- KRON $1.63
- AVG Volume (30 Days)
- FSI 24.7K
- KRON 933.7K
- Earning Date
- FSI 05-23-2025
- KRON 05-27-2025
- Dividend Yield
- FSI 2.40%
- KRON N/A
- EPS Growth
- FSI 9.09
- KRON N/A
- EPS
- FSI 0.24
- KRON N/A
- Revenue
- FSI $38,234,860.00
- KRON $9,192,000.00
- Revenue This Year
- FSI $21.91
- KRON N/A
- Revenue Next Year
- FSI $42.35
- KRON N/A
- P/E Ratio
- FSI $17.33
- KRON N/A
- Revenue Growth
- FSI N/A
- KRON 21.16
- 52 Week Low
- FSI $1.65
- KRON $0.67
- 52 Week High
- FSI $7.24
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- FSI 54.63
- KRON 34.95
- Support Level
- FSI $3.55
- KRON $0.70
- Resistance Level
- FSI $5.09
- KRON $0.75
- Average True Range (ATR)
- FSI 0.27
- KRON 0.04
- MACD
- FSI 0.12
- KRON -0.01
- Stochastic Oscillator
- FSI 47.08
- KRON 19.64
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.